Children with Primary Septic Arthritis Have a Markedly Lower Risk of Adverse Outcomes Than Those with Contiguous

Elizabeth C Hamilton1, Mary C Villani1, Mary M Klosterman1

  • 1Children's Health System of Texas, Dallas, Texas.

Insights

Septic arthritis in children with osteomyelitis presents differently than primary septic arthritis, leading to worse outcomes. Differentiating these conditions is crucial for effective treatment and improved long-term results in pediatric joint infections.

Area of Science:

  • Pediatric Orthopedics
  • Pediatric Infectious Diseases
  • Pediatric Rheumatology

Background:

  • Septic arthritis in children can lead to severe joint damage and long-term complications if not treated promptly.
  • Distinguishing between primary septic arthritis and septic arthritis with contiguous osteomyelitis is critical for risk assessment.

Purpose of the Study:

  • To compare outcomes in children with primary septic arthritis versus those with septic arthritis and adjacent osteomyelitis.
  • To identify clinical and laboratory differences that influence adverse outcomes in pediatric septic arthritis.

Main Methods:

  • Retrospective study of children treated for septic arthritis (with or without osteomyelitis) between 2009-2019.
  • Comparison of clinical, laboratory, treatment, and outcome data between two patient cohorts.

Main Results:

  • Children with osteomyelitis were older, had higher inflammatory markers (CRP), and more frequent bacteremia.
  • Staphylococcus aureus was a more common pathogen in osteomyelitis cases, while Kingella kingae was more prevalent in primary septic arthritis.
  • Septic arthritis with osteomyelitis was associated with longer hospitalizations, higher intensive care rates, readmissions, and overall complications.

Conclusions:

  • Primary septic arthritis and septic arthritis with contiguous osteomyelitis are distinct conditions in children.
  • Contiguous osteomyelitis is a significant driver of adverse outcomes in pediatric septic arthritis.
  • Identifying these differences aids in tailoring management, including imaging, antibiotic duration, and follow-up, to mitigate long-term complications.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
106
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
189
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
76
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
70
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
96